PIKFYVE expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.52680001974659E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.70099999996509E-06 |
Normal-vs-Stage2 |
2.216100E-03 |
Normal-vs-Stage3 |
2.45229947459791E-10 |
Normal-vs-Stage4 |
1.75479997199801E-09 |
Stage1-vs-Stage2 |
8.016600E-01 |
Stage1-vs-Stage3 |
5.758200E-03 |
Stage1-vs-Stage4 |
8.503800E-03 |
Stage2-vs-Stage3 |
1.173980E-01 |
Stage2-vs-Stage4 |
1.253830E-01 |
Stage3-vs-Stage4 |
8.509800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.05180003490335E-09 |
Normal-vs-AfricanAmerican |
2.17750000031103E-07 |
Normal-vs-Asian |
4.140200E-01 |
Caucasian-vs-AfricanAmerican |
3.090000E-01 |
Caucasian-vs-Asian |
2.616600E-01 |
AfricanAmerican-vs-Asian |
1.130160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.56220036906518E-10 |
Normal-vs-Female |
1.65431999999965E-05 |
Male-vs-Female |
3.485900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.53620000001398E-06 |
Normal-vs-Age(41-60Yrs) |
1.470399999981E-06 |
Normal-vs-Age(61-80Yrs) |
7.09169944990151E-10 |
Normal-vs-Age(81-100Yrs) |
4.4333000000063E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.394830E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.400600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.126600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.741800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.084800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.566000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.680000E-01 |
Normal-vs-Grade 2 |
2.41729999999052E-05 |
Normal-vs-Grade 3 |
7.21519954893779E-10 |
Normal-vs-Grade 4 |
1.17129639320979E-11 |
Grade 1-vs-Grade 2 |
2.298200E-01 |
Grade 1-vs-Grade 3 |
1.602380E-02 |
Grade 1-vs-Grade 4 |
1.636330E-03 |
Grade 2-vs-Grade 3 |
1.536450E-02 |
Grade 2-vs-Grade 4 |
1.415190E-04 |
Grade 3-vs-Grade 4 |
3.680000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.382950E-03 |
Normal-vs-ccB subtype |
1.93299998230145E-09 |
ccA subtype-vs-ccB subtype |
2.193000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.37059999963485E-07 |
Normal-vs-N1 |
4.229600E-04 |
N0-vs-N1 |
3.857600E-01 |
|
|